YGION Biomedical

Vienna, Austria

YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.

$16.3M raised

May 2024

Series A

Biotechnology Oncology Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about YGION Biomedical

How much funding has YGION Biomedical raised?

YGION Biomedical has raised $16.3M in total funding. The most recent round was Series A. The last funding was announced in May 2024.

Where is YGION Biomedical headquartered?

YGION Biomedical is headquartered in Vienna, Austria.

What does YGION Biomedical do?

YGION Biomedical is an Austrian biotechnology firm committed to making personalized cancer immunotherapy a reality.

What stage is YGION Biomedical at?

YGION Biomedical is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 21, 2024.

MLA

"YGION Biomedical — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/ygion-biomedical. Accessed July 2, 2026.

APA

VCBacked. (2024). YGION Biomedical — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/ygion-biomedical

Wikipedia (cite web)

{{cite web |title=YGION Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/ygion-biomedical |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 21, 2024.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K